Raised €30M+ Series B (Jan 2026) with Gates Foundation as cornerstone investor. Novel Binding Proteins (Helm brand) for gut health launching in US in 2026.
Bactolife is a Danish precision fermentation company developing Binding Proteins — a novel functional protein category inspired by camelid immunoglobulins (nanobodies) and produced through microbial fermentation. Marketed under the Helm brand, these proteins are designed to support gut health by binding to harmful pathogens and inflammatory triggers in the digestive system. The company raised €30 million+ in Series B financing in January 2026, co-led by Cross Border Impact Ventures and the Danish Green Future Fund, with the Gates Foundation as a cornerstone investor.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.